Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy (Q33592250)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy |
scientific article |
Statements
1 reference
Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy (English)
1 reference
Masahiko Takahashi
1 reference
Hidetsugu Saito
1 reference
Makiko Higashimoto
1 reference
Kazuhiro Atsukawa
1 reference
Hiromasa Ishii
1 reference
1 January 2005
1 reference
1 reference
43
1 reference
186-191
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference